0

Hypertension Collection
 21-40 of 50 Articles
ACP Journal Club |  21 June 2011
Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension
Jay N. Cohn, MD
Ann Intern Med. 2011;154(12):JC6-6. doi:10.7326/0003-4819-154-12-201106210-02006
ACP Journal Club |  17 May 2011
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Reem Mustafa, MD, MPH; Amit X. Garg, MD, PhD
Ann Intern Med. 2011;154(10):JC5-5. doi:10.7326/0003-4819-154-10-201105170-02005
ACP Journal Club |  17 May 2011
Review: Low-dose hydrochlorothiazide is not as effective as other antihypertensive drugs for reducing ambulatory BP in hypertension?
Eugene Yang, MD, FACC
Ann Intern Med. 2011;154(10):JC5-8. doi:10.7326/0003-4819-154-10-201105170-02008
ACP Journal Club |  15 February 2011
Pharmacist–physician hypertension comanagement reduced 24-hour ambulatory blood pressure
Brett D. Montgomery, MBBS, DCH, FRACGP
Ann Intern Med. 2011;154(4):JC2-9. doi:10.7326/0003-4819-154-4-201102150-02009
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  19 October 2010
Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes
Srinivas Merugu, MD
Ann Intern Med. 2010;153(8):JC4-2. doi:10.7326/0003-4819-153-8-201010190-02002
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  15 June 2010
Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors
Michael Farkouh, MD, MSc
Ann Intern Med. 2010;152(12):JC6-9. doi:10.7326/0003-4819-152-12-201006150-02009
ACP Journal Club |  15 June 2010
Aspirin did not prevent vascular events or mortality in adults with a low ankle–brachial index
A.C. Felix Burden, MD
Ann Intern Med. 2010;152(12):JC6-11. doi:10.7326/0003-4819-152-12-201006150-02011
ACP Journal Club |  18 May 2010
Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBs
Vibhuti Singh, MD, MPH
Ann Intern Med. 2010;152(10):JC5-3. doi:10.7326/0003-4819-152-10-201005180-02003
ACP Journal Club |  16 February 2010
Review: Early treatment of a cardiovascular event with nitrates or ACE inhibitors reduces short-term mortality
Jason Bradfield, MD; Kalyanam Shivkumar, MD, PhD
Ann Intern Med. 2010;152(4):JC2-3. doi:10.7326/0003-4819-152-4-201002160-02003
ACP Journal Club |  19 January 2010
Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension
Nirav R. Shah, MD, MPH; Gbenga Ogedegbe, MD, MPH, MS
Ann Intern Med. 2010;152(2):JC1-4. doi:10.7326/0003-4819-152-2-201001190-02004
ACP Journal Club |  17 November 2009
Review: Low BP targets do not reduce mortality or CV events in hypertension
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-6. doi:10.7326/0003-4819-151-10-200911170-02006
ACP Journal Club |  17 November 2009
Tight BP control reduced left ventricular hypertrophy in nondiabetic patients with hypertension
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-7. doi:10.7326/0003-4819-151-10-200911170-02007
ACP Journal Club |  18 August 2009
Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction
Peter Liu, MD
Ann Intern Med. 2009;151(4):JC2-9. doi:10.7326/0003-4819-151-4-200908180-02009
ACP Journal Club |  18 August 2009
Review: Combining 2 classes of blood pressure–lowering drugs has an approximately additive effect on systolic blood pressure
Alena Shantsila, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2009;151(4):JC2-11. doi:10.7326/0003-4819-151-4-200908180-02011
ACP Journal Club |  19 May 2009
What kind of randomized trials do patients and clinicians need?
Merrick Zwarenstein, MBBCh, MSc; Shaun Treweek, PhD
Ann Intern Med. 2009;150(10):JC5-2. doi:10.7326/0003-4819-150-10-200905190-02002
ACP Journal Club |  19 May 2009
Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
Simon W. Rabkin, MD
Ann Intern Med. 2009;150(10):JC5-8. doi:10.7326/0003-4819-150-10-200905190-02008
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  17 February 2009
Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors
Robin J. Taylor, MD
Ann Intern Med. 2009;150(4):JC2-6. doi:10.7326/0003-4819-150-4-200902170-02006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)